Search

Author/Creator Bachier, Carlos

1. 278 Phase I clinical trial evaluating the safety of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ advanced non-small cell lung cancer. (10th December 2020)

Authors:
Blumenschein, George; Devarakonda, Siddhartha; Johnson, Melissa; Moreno, Victor; Gainor, Justin; Edelman, Martin; Heymach, John; Govindan, Ramaswamy; Bachier, Carlos; Spéville, Bernard Doger de; Frigault, Matthew; Olszanski, Anthony; Lam, Vincent; Hyland, Natalie; Navenot, Jean-Marc; Fayngerts, S...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A169
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 278 Phase I clinical trial evaluating the safety of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ advanced non-small cell lung cancer. (9th November 2020)

Authors:
Blumenschein, George; Devarakonda, Siddhartha; Johnson, Melissa; Moreno, Victor; Gainor, Justin; Edelman, Martin; Heymach, John; Govindan, Ramaswamy; Bachier, Carlos; Spéville, Bernard Doger de; Frigault, Matthew; Olszanski, Anthony; Lam, Vincent; Hyland, Natalie; Navenot, Jean-Marc; Fayngerts, S...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A303
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer. Issue 1 (27th January 2022)

Authors:
Blumenschein, George R; Devarakonda, Siddhartha; Johnson, Melissa; Moreno, Victor; Gainor, Justin; Edelman, Martin J; Heymach, John V; Govindan, Ramaswamy; Bachier, Carlos; Doger de Spéville, Bernard; Frigault, Matthew J; Olszanski, Anthony J; Lam, Vincent K; Hyland, Natalie; Navenot, Jean-Marc; ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Survival outcomes of allogeneic hematopoietic cell transplants with EBV‐positive or EBV‐negative post‐transplant lymphoproliferative disorder, A CIBMTR study. Issue 5 (31st July 2019)

Authors:
Naik, Seema; Riches, Marcie; Hari, Parameswaran; Kim, Soyoung; Chen, Min; Bachier, Carlos; Shaughnessy, Paul; Hill, Joshua; Ljungman, Per; Battiwalla, Minoo; Chhabra, Saurabh; Daly, Andrew; Storek, Jan; Ustun, Celalettin; Diaz, Miguel Angel; Cerny, Jan; Beitinjaneh, Amer; Yared, Jean; Brown, Vale...
Journal:
Transplant infectious disease
Issue:
Volume 21:Issue 5(2019)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The impact of early versus late tocilizumab administration in patients with cytokine release syndrome secondary to immune effector cell therapy. (January 2023)

Authors:
Peaytt, Rachel; Parsons, Laura Beth; Siler, Darby; Matthews, Rachel; Li, Belinda; Bell, David; Bachier, Carlos; Pantin, Jeremy; Berdeja, Jesus; Flinn, Ian; Donnellan, William; Battiwalla, Minoo
Journal:
Journal of oncology pharmacy practice
Issue:
Volume 29:Number 1(2023)
Page Start:
45
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Treatment of Acquired von Willebrand Syndrome and Prevention of Bleeding Postautologous Stem Cell Transplant during Severe Pancytopenia with IVIG. (2nd April 2015)

Authors:
Zoghi, Behyar; Shaughnessy, Paul; Lyons, Roger M.; Helmer, Richard; Bachier, Carlos; LeMaistre, C. Frederick
Other Names:
Khair Kate Academic Editor.
Journal:
Case reports in hematology
Issue:
Volume 2015(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗